BHC [NYSE]
Bausch Health Companies Inc.
Index- P/E58.89 EPS (ttm)0.12 Insider Own2.30% Shs Outstand362.20M Perf Week-2.13%
Market Cap2.53B Forward P/E1.64 EPS next Y4.19 Insider Trans-0.02% Shs Float345.71M Perf Month15.41%
Income43.00M PEG6.77 EPS next Q0.96 Inst Own66.80% Short Float6.20% Perf Quarter-19.23%
Sales8.19B P/S0.31 EPS this Y-67.40% Inst Trans18.96% Short Ratio2.41 Perf Half Y-69.85%
Book/sh-1.91 P/B- EPS next Y27.40% ROA0.10% Target Price- Perf Year-75.26%
Cash/sh1.80 P/C3.84 EPS next 5Y8.70% ROE-14.10% 52W Range4.00 - 29.31 Perf YTD-75.05%
Dividend- P/FCF6.18 EPS past 5Y17.60% ROI2.10% 52W High-76.49% Beta1.10
Dividend %- Quick Ratio0.90 Sales past 5Y-2.70% Gross Margin71.50% 52W Low72.25% ATR0.56
Employees19600 Current Ratio1.10 Sales Q/Q-6.30% Oper. Margin18.20% RSI (14)49.48 Volatility7.69% 8.93%
OptionableYes Debt/Eq- EPS Q/Q75.80% Profit Margin0.50% Rel Volume0.58 Prev Close6.95
ShortableYes LT Debt/Eq- EarningsAug 09 BMO Payout0.00% Avg Volume8.88M Price6.89
Recom2.30 SMA20-3.49% SMA506.55% SMA200-56.48% Volume5,188,275 Change-0.86%
Jul-29-22Downgrade Truist Buy → Hold
Jul-29-22Downgrade RBC Capital Mkts Outperform → Sector Perform $12 → $5
Jul-28-22Downgrade JP Morgan Overweight → Neutral
Jun-13-22Resumed JP Morgan Overweight $12
Mar-24-21Downgrade BofA Securities Neutral → Underperform $27
Feb-17-21Upgrade RBC Capital Mkts Sector Perform → Outperform $26 → $42
Jan-22-21Downgrade Piper Sandler Overweight → Neutral $25 → $30
Sep-17-20Upgrade BofA Securities Underperform → Neutral $19
Aug-24-20Reiterated H.C. Wainwright Buy $64 → $50
Aug-24-20Reiterated H.C. Wainwright Buy $50 → $64
Jun-17-20Reiterated H.C. Wainwright Buy $50 → $64
Apr-24-20Initiated Citigroup Buy $30
Apr-02-20Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20Upgrade Wells Fargo Underweight → Equal Weight $32
Dec-12-19Upgrade JP Morgan Neutral → Overweight $32 → $38
Dec-02-19Initiated Goldman Neutral
Oct-25-19Initiated Cowen Outperform $35
Sep-12-19Initiated Guggenheim Buy
Aug-15-19Upgrade TD Securities Hold → Buy
Sep-28-22 08:09AM
Sep-23-22 06:59AM
Sep-22-22 07:57AM
Sep-20-22 09:03AM
Sep-14-22 11:20AM
09:00AM Loading…
09:00AM
Sep-11-22 09:06AM
Sep-09-22 07:00AM
07:00AM
Sep-08-22 04:45PM
11:30AM
Sep-06-22 06:10AM
Sep-02-22 05:15PM
02:43PM
Sep-01-22 02:34PM
02:53PM Loading…
Aug-31-22 02:53PM
11:07AM
Aug-30-22 11:28PM
Aug-29-22 12:43PM
Aug-22-22 07:00AM
Aug-15-22 10:05AM
Aug-12-22 06:10AM
Aug-10-22 06:00PM
06:00PM
11:56AM
07:00AM
07:00AM
Aug-09-22 04:42PM
09:19AM
08:35AM
08:22AM Loading…
08:22AM
07:25AM
07:00AM
07:00AM
Aug-08-22 09:14AM
Aug-04-22 05:25PM
03:00PM
07:36AM
Aug-03-22 05:35PM
Aug-02-22 12:14PM
10:00AM
Aug-01-22 06:15PM
11:06AM
Jul-29-22 01:57PM
01:44PM
10:34AM
09:35AM
Jul-28-22 04:50PM
03:56PM
03:47PM
03:45PM
02:34PM
10:51AM
10:33AM
10:30AM
10:18AM
10:12AM
10:12AM
10:03AM
09:29AM
09:04AM
Jul-27-22 07:00PM
Jul-26-22 03:45PM
Jul-20-22 07:00AM
07:00AM
Jul-13-22 07:00AM
Jul-11-22 09:17AM
Jul-06-22 09:14AM
Jul-02-22 10:30AM
Jul-01-22 09:20AM
Jun-24-22 09:22PM
01:37PM
09:47AM
09:21AM
06:23AM
Jun-23-22 04:54PM
Jun-21-22 07:00AM
07:00AM
Jun-20-22 07:00AM
03:00AM
Jun-19-22 04:52PM
Jun-17-22 09:36AM
08:22AM
05:09AM
Jun-16-22 07:59PM
05:48PM
05:30PM
Jun-15-22 09:42AM
Jun-10-22 04:13PM
Jun-09-22 11:30AM
Jun-08-22 07:17AM
Jun-06-22 08:48AM
Jun-02-22 05:00PM
08:57AM
Jun-01-22 05:21PM
May-19-22 06:59AM
May-18-22 07:00AM
May-12-22 08:21PM
May-11-22 07:00AM
May-10-22 04:05PM
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bausch Health Companies Inc.10% OwnerJun 01Sale17.054,550,35777,606,339310,449,643Jun 02 04:05 PM
Bausch Health Companies Inc.10% OwnerMay 10Sale17.0535,000,000596,925,000315,000,000May 12 04:18 PM
Spurr RobertU.S. President-Pharma BusinessApr 14Sale22.191,59535,39390,506Apr 15 04:32 PM
Spurr RobertU.S. President-Pharma BusinessMar 15Sale22.204,846107,58192,101Mar 16 04:39 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 08Sale21.763,88984,62593,139Mar 10 04:03 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 02Sale23.3711,077258,869101,102Mar 04 04:58 PM
Spurr RobertU.S. President-Pharma BusinessMar 02Sale23.371,59537,27565,394Mar 04 04:09 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 01Sale23.826,338150,971112,179Mar 02 09:29 PM
Spurr RobertU.S. President-Pharma BusinessFeb 15Sale25.023,25181,34060,299Feb 17 04:36 PM
Spurr RobertU.S. President-Pharma BusinessJan 18Sale26.633,25186,57463,550Jan 20 07:55 PM
Miller Steven DDirectorNov 30Buy24.1710,000241,69910,000Dec 02 07:15 PM
Miller Steven DDirectorNov 30Buy24.2450,0001,211,82560,780Dec 02 07:15 PM